Effects of Attention Bias Modification on Cognitive Decline in Breast Cancer Patients

Effects of Attention Bias Modification on Cognitive dysfunction in Breast Cancer Patients - Effects of Attention Bias Modification on Cognitive dysfunction in Breast Cancer Patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057778

Enrollment

Registered

2025-05-05

Start date

2025-05-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

attention bias modification Placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female breast cancer patients undergoing preoperative and postoperative adjuvant chemotherapy Patients undergoing chemotherapy for recurrent breast cancer Breast cancer patients in outpatient care following chemotherapy

Exclusion criteria

Exclusion criteria: Patients with distant metastasis Patients with psychiatric disorders such as schizophrenia or depression Patients with obvious cognitive decline due to dementia Patients in extremely poor general condition

Design outcomes

Primary

Measure	Time frame
FACT-Cog	—

Secondary

Measure	Time frame
TMT, HVLT-R, verbal fluency task, attention bias, HADS, CFS	—

Countries

Japan

Contacts

Public ContactYuta Ikio

Kumamoto health Science University Faculty of Health Science, Department of Rehabilitation, Occupational Therapy

ikio@kumamoto-hsu.ac.jp096-275-2167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026